<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Myocardial bridging of the coronary arteries</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Myocardial bridging of the coronary arteries</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Myocardial bridging of the coronary arteries</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Sorajja, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ami E Iskandrian, MD, MACC, MASNC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Giuseppe Tarantini, MD, PhD, FESC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephan Windecker, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The major coronary arteries, which are distributed over the epicardial surface of the heart, occasionally have a segment that is intramyocardial. The muscle overlying the intramyocardial segment of an epicardial coronary artery (most often the left anterior descending artery) is referred to as a "myocardial bridge."</p><p>This topic will review the epidemiology, anatomy, physiology, diagnosis, and clinical management of myocardial bridging. Other relevant topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/100408.html" rel="external">"Myocardial infarction or ischemia with no obstructive coronary atherosclerosis", section on 'Coronary artery spasm'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1472.html" rel="external">"Approach to the patient with suspected angina pectoris", section on 'Conditions causing or worsening angina'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1536.html" rel="external">"Congenital and pediatric coronary artery abnormalities", section on 'Causes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4948.html" rel="external">"Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, and evaluation", section on 'Clinical manifestations'</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>The prevalence of bridging varies according to the population studied and the method used to assess the coronary anatomy. Pathologic studies have found a mean frequency of myocardial bridging of 25 percent (range 5 to 86 percent), similar to that observed in noninvasive imaging studies using coronary computed tomography [<a href="#rid1">1-7</a>]. In one autopsy study, the prevalence was 50 percent [<a href="#rid3">3</a>]</p><p>Angiographic studies have noted somewhat different findings. Among patients undergoing coronary angiography, the reported prevalence of myocardial bridging is 1.7 percent (range 0.5 to 16 percent), which is almost always confined to the left anterior descending coronary artery  (<a class="graphic graphic_diagnosticimage graphicRef50411" href="/z/d/graphic/50411.html" rel="external">image 1</a>) [<a href="#rid1">1,2,8-13</a>]. A higher prevalence has been observed in patients with hypertrophic cardiomyopathy and in recipients of cardiac transplants [<a href="#rid1">1,13-15</a>]. (See <a class="local">'Patients with hypertrophic cardiomyopathy'</a> below.)</p><p>Among patients with myocardial infarction with nonobstructive coronary arteries (MINOCA), the prevalence of bridging is higher (2.9 percent) than observed in patients with coronary artery disease [<a href="#rid16">16</a>]. </p><p>The difference in prevalence when estimated by these modalities reflects the fact that angiographic evidence of myocardial bridging depends upon a variety of factors, including the thickness of the myocardium, the length of the bridged segment, the orientation of the coronary artery to the myocardial fibers, the nature of the tissue interposed between the coronary artery and the myocardium, the observer's experience, and the intensity with which bridging is sought. We believe bridging often goes unrecognized on angiography.</p><p>In one study of 100 patients using computed tomography angiography (CTA), myocardial bridging of coronary arteries was found in 34 percent, but only approximately one-third of these showed systolic compression [<a href="#rid17">17</a>]. In another study using CTA, myocardial bridging was found to be a common anatomic variant [<a href="#rid18">18</a>]. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">ANATOMY</span><span class="headingEndMark"> — </span>The site, length, and severity of bridging vary from patient to patient and may vary in the same patient from one examination to another. Although all major epicardial coronary arteries can be affected, involvement of the left anterior descending coronary artery (LAD) is the most common. </p><p>The degree of bridging is usually neither extensive nor severe. However, there is a large degree of variability among patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Bridging may vary in terms of depth (superficial [&gt;1 to 2 mm] versus deep [&gt;2 mm]) and length of the tunneled artery encasement. When a large segment of the vessel is involved, extending from the origin to more than two-thirds of the vessel length, bridging may jeopardize the flow to secondary branches [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In some cases, bridging is so severe that there is almost complete obliteration of the vessel lumen during systole  (<a class="graphic graphic_diagnosticimage graphicRef50411" href="/z/d/graphic/50411.html" rel="external">image 1</a>) [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bridging can involve the secondary branches, especially the septal perforators  (<a class="graphic graphic_picture graphicRef73855" href="/z/d/graphic/73855.html" rel="external">picture 1</a>). Systolic compression of septal perforators appears to be more common in patients with hypertrophic cardiomyopathy, in whom it has been postulated to be one of several mechanisms responsible for myocardial ischemia. (See <a class="local">'Patients with hypertrophic cardiomyopathy'</a> below.)</p><p></p><p class="headingAnchor" id="H4"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Most instances of bridging are of little clinical significance. However, severe bridging of the major coronary arteries can produce myocardial ischemia, coronary thrombosis, myocardial infarction, and stress cardiomyopathy (see  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a>), and can predispose the patient to sudden death [<a href="#rid3">3,8,20-26</a>]. </p><p class="headingAnchor" id="H5"><span class="h2">Effects on coronary blood flow</span><span class="headingEndMark"> — </span>The effects of myocardial bridging on myocardial blood flow vary from patient to patient and within the same patient. </p><p>This variability arises from variation in the extent of myocardial bridging, the fact that myocardial blood flow occurs predominantly during diastole, when bridging is not usually present, and challenges in methods of detection of ischemia due to myocardial bridging.</p><p class="bulletIndent1"><span class="glyph">●</span>Frame-by-frame analysis of cine coronary angiograms has shown a "spill-over" phenomenon that is characterized by persistence of narrowing of the bridged segment in early diastole. In general, the more severe the systolic narrowing is, the more likely that the phasic coronary spasm will prolong into diastole.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>With tachycardia, there is more systolic compression of the bridged segment, and systole occupies a greater percentage of the cardiac cycle because of shortening of diastolic filling period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During left ventricular systole, the intramuscular segment of the vessel is compressed, a condition referred to as "milking" [<a href="#rid1">1,2</a>]. Myocardial bridge "milking" might also cause ischemia by "intramural steal" or "branch steal" mechanism, which are linked to decreased perfusion pressure of septal branches and blood suction [<a href="#rid25">25</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In vitro models show that regardless of the degree of stenosis, myocardial bridges have a higher maximum and lower mean pressure drop than typical atherosclerotic lesions [<a href="#rid27">27</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial bridging may cause myocardial ischemia by impairing coronary vasomotility. To this regard, it has been associated with a higher incidence of endothelial dysfunction and coronary artery spasm. Provocation test using incremental acetylcholine dose infusion may reveal coronary vasospasm in patients with bridging [<a href="#rid28">28,29</a>]. </p><p></p><p>Quantitative coronary angiography has been combined with intravascular ultrasound (IVUS) and Doppler flow measurements in patients with isolated bridging of the proximal left anterior descending coronary artery [<a href="#rid1">1,9-13,30-32</a>]. (See  <a class="medical medical_review" href="/z/d/html/16536.html" rel="external">"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation"</a> and  <a class="medical medical_review" href="/z/d/html/1514.html" rel="external">"Clinical use of coronary artery pressure flow measurements"</a>.)</p><p>The following observations have been made [<a href="#rid9">9,10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A specific, echolucent half-moon phenomenon over the bridge segment, which exists throughout the cardiac cycle and whose etiology is not completely understood.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A characteristic systolic compression (either concentric or eccentric) with delayed relaxation in diastole of the myocardial bridging segment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Accelerated flow at early diastole (finger-tip phenomenon) with either no or reduced systolic antegrade flow  (<a class="graphic graphic_figure graphicRef55472" href="/z/d/graphic/55472.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased diastolic/systolic velocity ratio.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Retrograde flow in the proximal segment, which is provoked and enhanced by <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> injection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The cross-sectional lumen area variation in one report was 40±25 percent in the bridging segments versus 9±7 percent in the normal segments. Atherosclerotic lesions occurred proximal to, but not within or distal to, the bridging segments [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A highly characteristic pattern showing a prominent peak in coronary velocity in early diastole was seen in 86 percent of patients  (<a class="graphic graphic_figure graphicRef55472" href="/z/d/graphic/55472.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The coronary flow velocity reserve ratio (peak/resting ratio) was 2.2, which is below normal, possibly due to delayed release of bridging and/or proximal atherosclerosis; this finding may explain signs of ischemia in some of these patients.</p><p></p><p>Fractional flow reserve (FFR) was measured at baseline and during <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a> infusion in a study of 12 patients with myocardial bridging [<a href="#rid32">32</a>]. The mean and diastolic FFR decreased from baseline with dobutamine, with the diastolic change being more prominent. The authors postulated that overshooting of systolic pressure interferes with and is a cause of error in FFR measurement based upon mean pressures, while the diastolic FFR appears to be the method of choice. Other reports have emphasized the use of dobutamine rather than <a class="drug drug_general" data-topicid="9359" href="/z/d/drug information/9359.html" rel="external">adenosine</a> when assessing myocardial bridging with FFR [<a href="#rid33">33</a>].</p><p>Another study found that in the presence of a myocardial bridge, instantaneous wave free-ratio (iFR), a lesion-specific, diastole-only index, has a greater correlation to anginal symptoms or presence of myocardial ischemia as compared with FFR [<a href="#rid34">34</a>]. Out of 20 patients with angina, no significant coronary artery disease, and angiographic evidence of a myocardial bridge, 65 percent had positive iFR at rest (with a clear step-up across the myocardial bridge, as shown during pressure wire pullback), while FFR was negative in all patients. Moreover, after <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a> infusion, when vessel compression was maximal and patients developed symptoms, FFR did not significantly change while iFR (better defined as "hyperemic wave-free period pressure ratio") dropped in all cases. </p><p>Even if the diagnostic and prognostic values of the latter index remain to be established, these findings show that iFR seems more reliable than FFR to detect myocardial bridge-related ischemia, being that iFR is a diastolic-specific parameter and therefore not hampered by systolic-pressure overshooting. </p><p class="headingAnchor" id="H6"><span class="h2">Bridging and atherosclerosis</span><span class="headingEndMark"> — </span>It has been postulated that the intramyocardial course of the coronary artery has a "protective" effect on the development of atherosclerosis at the site of the myocardial bridge [<a href="#rid35">35</a>]. However, some studies have reported concentric intimal thickening of the artery underneath the bridges, and increased atherosclerotic plaques proximal to the bridging [<a href="#rid3">3,12</a>]. This has been seen both pathologically and with the use of IVUS [<a href="#rid10">10</a>]. Increased wall shear stress proximal to bridging segment is thought to predispose to the development of atherosclerosis [<a href="#rid36">36</a>].</p><p>Myocardial bridging can occur in patients with and without coronary artery disease, including disease in the same vessel. In addition, we have seen patients in whom bridging became apparent only after percutaneous coronary intervention of a more proximal segment with fixed stenosis.</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL RELEVANCE</span><span class="headingEndMark"> — </span>In the majority of patients, myocardial bridging is not associated with adverse clinical sequelae.</p><p>However, patients may present with silent ischemia, stable angina, acute coronary syndromes, stress cardiomyopathy, or malignant arrhythmias possibly leading to sudden cardiac death [<a href="#rid1">1,37-39</a>]. The following are representative findings from small series:</p><p class="bulletIndent1"><span class="glyph">●</span>In clinical studies using stress myocardial perfusion imaging, the rate of myocardial ischemia has varied widely (21 to 88 percent) [<a href="#rid40">40</a>]. This variation is likely due to differences in the populations studied and the type of stress and imaging performed. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 11 patients with bridging who were evaluated with both pacing and exercise, five patients had more than 75 percent systolic narrowing [<a href="#rid8">8</a>]. Of these, four had ST-segment depression and increased coronary sinus lactate production with pacing at 150 beats per minute (bpm). Of the four patients with 50 to 75 percent systolic narrowing, two had angina and electrocardiogram (ECG) changes with pacing at 150 bpm. In the two patients with less than 50 percent bridging, neither had ECG changes, lactate production, or symptoms with either pacing or exercise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a report of 39 patients with myocardial bridging who underwent stress myocardial perfusion imaging, eight (20.5 percent) were found to have perfusion defects in the distribution of the bridge [<a href="#rid40">40</a>]. The myocardial ischemia was associated more closely with the degree of systolic narrowing than with the length of the tunneled artery or the location of the bridge.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are few reports of survival rates but, when studied, five-year survival ranges between 85 and 98 percent [<a href="#rid12">12,13,41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bridging may affect survival of pediatric patients with hypertrophic cardiomyopathy (HCM) but has not been found to influence prognosis of adult patients. (See <a class="local">'Patients with hypertrophic cardiomyopathy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial bridging has been linked in selected cases to acute myocardial infarction [<a href="#rid21">21,42,43</a>], paroxysmal supraventricular tachycardia [<a href="#rid21">21</a>], ventricular tachycardia [<a href="#rid2">2,37,43</a>], exercise-induced atrioventricular conduction block [<a href="#rid44">44</a>], and sudden death [<a href="#rid2">2,45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One study showed that myocardial bridging with systolic-dynamic compression of a left anterior descending coronary artery (LAD) segment is a frequent finding in patients with stress cardiomyopathy, suggesting a role of myocardial bridging as a potential substrate in the pathogenesis of this condition [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a>.)</p><p></p><p>Some previously asymptomatic individuals may become symptomatic. Pathophysiologic factors that may unmask or exacerbate myocardial bridges are a patient's age, heart rate, left ventricular hypertrophy, and the presence of coronary atherosclerosis, since all of these may worsen the supply-demand mismatch imposed by the bridge, reducing coronary reserve [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Patients with hypertrophic cardiomyopathy</span><span class="headingEndMark"> — </span>HCM in children is associated with a 2 to 6 percent annual mortality, primarily due to sudden cardiac death, which may result from arrhythmias or myocardial ischemia. One possible cause for myocardial ischemia and a poorer outcome in these children is myocardial bridging, which appears to be especially common in this population. (See  <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">"Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis", section on 'Signs and symptoms'</a>.)</p><p>Reports have suggested that bridging in children with HCM is an important risk factor for cardiac complications [<a href="#rid47">47,48</a>]. The potential risk was illustrated in an angiographic study of 36 children with HCM, 10 of whom (28 percent) had myocardial bridging of the LAD persisting for 50 percent of diastole [<a href="#rid47">47</a>]. The following findings were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Compared with patients without bridging, those with bridging had a significantly greater incidence of chest pain (60 versus 19 percent), history of resuscitated cardiac arrest (50 versus 4 percent), and ventricular tachycardia on ambulatory monitoring (80 versus 8 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>With exercise testing, the patients with myocardial bridging had a reduction in blood pressure (rather than the increase seen in those without bridging), a greater degree of ST-segment depression, and more QT dispersion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The estimated proportion of patients free from death or resuscitated cardiac arrest at five years was significantly lower among those with bridging (67 versus 94 percent).</p><p></p><p>A later report evaluated 57 children with HCM, 23 of whom (40 percent) had myocardial bridging [<a href="#rid48">48</a>]. Bridging was associated with more severe left ventricular hypertrophy but not ischemia or sudden death [<a href="#rid48">48</a>].</p><p>In adults with HCM, a high prevalence of myocardial bridging also has been observed, with bridging observed in 15 percent of patients undergoing coronary angiography and in 41 percent in a necropsy study [<a href="#rid30">30,49</a>]. The link between the presence of bridging and impairment of survival, including risk of sudden death, has not been demonstrated in some studies [<a href="#rid13">13,50</a>], though there is controversy, as other studies have described such association with adverse events [<a href="#rid51">51,52</a>].</p><p class="headingAnchor" id="H440259395"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>In the majority of patients, myocardial bridging is asymptomatic. Symptomatic patients may present with clinical manifestations of myocardial ischemia that are similar to those in patients with fixed obstructive coronary artery disease such as an acute coronary syndrome, coronary spasm, exercise-induced dysrhythmias, atrioventricular conduction block, myocardial stunning, transient ventricular dysfunction, syncope, or sudden death [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/1472.html" rel="external">"Approach to the patient with suspected angina pectoris", section on 'History'</a> and <a class="local">'Clinical relevance'</a> above.)</p><p class="headingAnchor" id="H10"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of myocardial bridging is made when a section of an epicardial coronary artery (usually the left anterior descending coronary artery [LAD]) is found to be entirely or substantially within the myocardium (intramyocardial). This may be documented at the time of diagnostic coronary angiography, computed tomographic angiography, intraoperatively, or at postmortem examination. </p><p>With diagnostic coronary angiography, bridging is recognized as compression of a segment of a coronary artery during systole, resulting in narrowing that reverses during diastole  (<a class="graphic graphic_diagnosticimage graphicRef50411" href="/z/d/graphic/50411.html" rel="external">image 1</a>). The dynamic and phasic nature of the obstruction serves to differentiate bridging from fixed coronary stenosis. Bridging is easier to recognize in the left anterior oblique than right anterior oblique projection. </p><p>Provocation with <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> may be useful during coronary angiography, with careful attention to coronary filling during systole. Nitroglycerin <strong>augments</strong> the severity of compression, probably by reflex sympathetic stimulation of contractility and/or a lower intraluminal pressure in the coronary artery [<a href="#rid4">4</a>].</p><p>The diagnosis of myocardial bridging of the LAD should be considered in patients at low risk for atherosclerotic coronary artery disease, such as younger individuals or those with no atherosclerotic risk factors, who have exertional angina and an anteroseptal perfusion defect. </p><p class="headingAnchor" id="H1462299796"><span class="h2">Additional testing</span><span class="headingEndMark"> — </span>For some patients in whom the diagnosis of myocardial bridging has been secured, additional testing may be considered.</p><p>Intravascular ultrasound is useful to better characterize the length, thickness, and location of the myocardial bridge, as well as the presence, severity, and distribution of sub-angiographic atherosclerosis. Cardiac computed tomography is able to easily detect and characterize myocardial bridging, given its three-dimensional capability and high spatial and contrast resolution. It can visualize the coronary lumen, the vessel wall, and the myocardial wall, hence allowing accurate definition of the myocardial bridge's morphologic features and precise definition of the myocardial bridge's length and depth.</p><p>Diagnostic workup of a myocardial bridge should not be limited to its anatomic definition, but rather include physiologic evaluation of its hemodynamic significance. To this regard, Doppler-flow catheters or intracoronary pressure-wire evaluation with instantaneous wave-free ratio rather than fractional flow reserve seem to be informative, and should be performed at rest and after inotropic stimulus. (See  <a class="medical medical_review" href="/z/d/html/16536.html" rel="external">"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation"</a> and  <a class="medical medical_review" href="/z/d/html/1514.html" rel="external">"Clinical use of coronary artery pressure flow measurements"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Only symptomatic patients or those with objective signs of ischemia require treatment. Such individuals respond well to pharmacologic therapy, which appears to be the treatment of choice for the vast majority of subjects [<a href="#rid53">53,54</a>]. Only patients with symptoms refractory to medical therapy should be considered for percutaneous or surgical treatment.</p><p class="headingAnchor" id="H4124478886"><span class="h2">Medical therapy</span><span class="headingEndMark"> — </span>Pharmacologic treatment includes beta blockers, <a class="drug drug_general" data-topicid="101166" href="/z/d/drug information/101166.html" rel="external">ivabradine</a>, and possibly nondihydropyridine calcium channel blockers. These agents reduce heart rate and myocardial contractility. In particular, beta blockers are able to revert intracoronary-pressure changes and angina symptoms induced by inotropic infusion, and should therefore be considered as first-line therapy [<a href="#rid34">34</a>]. </p><p>Nitrates, by reducing the intrinsic coronary wall tension and increasing reflex sympathetic stimulation of contractility, may worsen symptoms, and their use is <strong>contraindicated</strong> [<a href="#rid2">2</a>]. </p><p>In the absence of evidence for atherosclerosis, we do not treat with <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> or a statin.</p><p class="headingAnchor" id="H1934781062"><span class="h2">Revascularization</span><span class="headingEndMark"> — </span>Preliminary studies suggest that intracoronary stent placement may normalize disturbed intracoronary hemodynamics and improve clinical symptoms in patients with symptomatic bridging [<a href="#rid55">55,56</a>]. However, relatively higher rates of target lesion revascularization (sometimes secondary to stent fracture [<a href="#rid57">57</a>]) may occur with stenting segments containing myocardial bridging [<a href="#rid49">49,58</a>]. In one study of 70 patients with myocardial bridging who had percutaneous coronary intervention predominantly with drug-eluting stents, target-lesion revascularization at mean follow-up of 358 days was 24 percent among patients who had stenting that extended into the segment containing myocardial bridging, in comparison to 3 percent among patients whose stent was implanted only in the epicardial obstructive lesion [<a href="#rid49">49</a>]. Of note, coronary artery perforation during stenting for myocardial bridging has been reported in several instances [<a href="#rid59">59,60</a>]. (See  <a class="medical medical_review" href="/z/d/html/1587.html" rel="external">"Intracoronary stent restenosis"</a>.)</p><p>Surgical therapy should be reserved for patients with persistent symptoms, in whom ischemic changes are proven, and for those with a high-risk marker (such as life-threatening ventricular arrhythmias, aborted sudden death, or nonfatal myocardial infarction), in whom a trial of medical therapy has failed. In patients with severe bridging and concomitant coronary artery disease who are undergoing coronary artery bypass surgery, an attempt should be made to relieve the bridge, which may compromise flow to proximal branches despite a patent graft to the distal vessel.</p><p>The operative procedure of choice is resection of the muscle bridge using cardiopulmonary bypass [<a href="#rid61">61-63</a>]. Dissection of the overlying myocardial fibers with complete exposure of the coronary artery is essential if recurrence is to be avoided. Some have combined this procedure with bypass grafting. Perforation of the right ventricle is a recognized complication; epicardial echocardiography with a high-frequency probe may help to identify the course of the vessel and thereby help reduce the risk of this complication [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H1305088850"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Introduction </strong>– The major coronary arteries may have a segmental intramyocardial course. During systole, this segment of the vessel is compressed, a condition referred to as "myocardial bridging." (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology and clinical relevance </strong>– Most instances of bridging have no clinical significance. However, severe bridging of the major coronary arteries can produce myocardial ischemia, coronary thrombosis, myocardial infarction, and stress cardiomyopathy. (See <a class="local">'Pathophysiology'</a> above and <a class="local">'Clinical manifestations'</a> above and <a class="local">'Clinical relevance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis of myocardial bridging is made when a section of an epicardial coronary artery (usually the left anterior descending coronary artery) is found to be entirely or substantially within the myocardium (intramyocardial). This may be documented at the time of diagnostic coronary angiography, computed tomographic angiography, intraoperatively, or at postmortem examination. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>– Medical therapy with beta blockers, <a class="drug drug_general" data-topicid="101166" href="/z/d/drug information/101166.html" rel="external">ivabradine</a>, and calcium channel blockers is effective in reducing symptoms in the vast majority of patients. However, <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> or other nitrate drugs may exacerbate bridging and are contraindicated. Coronary artery stent implantation and coronary artery surgery may be used to improve symptoms in patients who are refractory to medical therapy. (See <a class="local">'Treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Möhlenkamp S, Hort W, Ge J, Erbel R. Update on myocardial bridging. Circulation 2002; 106:2616.</a></li><li><a class="nounderline abstract_t">Alegria JR, Herrmann J, Holmes DR Jr, et al. Myocardial bridging. Eur Heart J 2005; 26:1159.</a></li><li><a class="nounderline abstract_t">Ishikawa Y, Akasaka Y, Suzuki K, et al. Anatomic properties of myocardial bridge predisposing to myocardial infarction. Circulation 2009; 120:376.</a></li><li><a class="nounderline abstract_t">Hongo Y, Tada H, Ito K, et al. Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound. Am Heart J 1999; 138:345.</a></li><li><a class="nounderline abstract_t">Iskandrian AE, Nallamothu N, Heo J. Nonatherosclerotic causes of myocardial ischemia. J Nucl Cardiol 1996; 3:428.</a></li><li><a class="nounderline abstract_t">La Grutta L, Runza G, Lo Re G, et al. Prevalence of myocardial bridging and correlation with coronary atherosclerosis studied with 64-slice CT coronary angiography. Radiol Med 2009; 114:1024.</a></li><li><a class="nounderline abstract_t">Hwang JH, Ko SM, Roh HG, et al. Myocardial bridging of the left anterior descending coronary artery: depiction rate and morphologic features by dual-source CT coronary angiography. Korean J Radiol 2010; 11:514.</a></li><li><a class="nounderline abstract_t">Faruqui AM, Maloy WC, Felner JM, et al. Symptomatic myocardial bridging of coronary artery. Am J Cardiol 1978; 41:1305.</a></li><li><a class="nounderline abstract_t">Ge J, Jeremias A, Rupp A, et al. New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J 1999; 20:1707.</a></li><li><a class="nounderline abstract_t">Ge J, Erbel R, Rupprecht HJ, et al. Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation 1994; 89:1725.</a></li><li><a class="nounderline abstract_t">Angelini P, Velasco JA, Flamm S. Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation 2002; 105:2449.</a></li><li><a class="nounderline abstract_t">Kramer JR, Kitazume H, Proudfit WL, Sones FM Jr. Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery. Am Heart J 1982; 103:283.</a></li><li><a class="nounderline abstract_t">Sorajja P, Ommen SR, Nishimura RA, et al. Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 42:889.</a></li><li><a class="nounderline abstract_t">Wymore P, Yedlicka JW, Garcia-Medina V, et al. The incidence of myocardial bridges in heart transplants. Cardiovasc Intervent Radiol 1989; 12:202.</a></li><li><a class="nounderline abstract_t">van der Velde N, Huurman R, Yamasaki Y, et al. Frequency and Significance of Coronary Artery Disease and Myocardial Bridging in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 2020; 125:1404.</a></li><li><a class="nounderline abstract_t">Matta A, Nader V, Canitrot R, et al. Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries. Eur Heart J Acute Cardiovasc Care 2022; 11:501.</a></li><li><a class="nounderline abstract_t">Uusitalo V, Saraste A, Pietilä M, et al. The Functional Effects of Intramural Course of Coronary Arteries and its Relation to Coronary Atherosclerosis. JACC Cardiovasc Imaging 2015; 8:697.</a></li><li><a class="nounderline abstract_t">Nakanishi R, Rajani R, Ishikawa Y, et al. Myocardial bridging on coronary CTA: an innocent bystander or a culprit in myocardial infarction? J Cardiovasc Comput Tomogr 2012; 6:3.</a></li><li><a class="nounderline abstract_t">Tarantini G, Migliore F, Cademartiri F, et al. Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach. J Am Coll Cardiol 2016; 68:2887.</a></li><li><a class="nounderline abstract_t">Noble J, Bourassa MG, Petitclerc R, Dyrda I. Myocardial bridging and milking effect of the left anterior descending coronary artery: normal variant or obstruction? Am J Cardiol 1976; 37:993.</a></li><li><a class="nounderline abstract_t">Morales AR, Romanelli R, Boucek RJ. The mural left anterior descending coronary artery, strenuous exercise and sudden death. Circulation 1980; 62:230.</a></li><li><a class="nounderline abstract_t">Utuk O, Bilge A, Bayturan O, et al. Thrombosis of a coronary artery related to the myocardial bridging. Heart Lung Circ 2010; 19:481.</a></li><li><a class="nounderline abstract_t">Hostiuc S, Curca GC, Dermengiu D, et al. Morphological changes associated with hemodynamically significant myocardial bridges in sudden cardiac death. Thorac Cardiovasc Surg 2011; 59:393.</a></li><li><a class="nounderline abstract_t">Husmann L, Nkoulou R, Wolfrum M, Kaufmann PA. Myocardial bridging causing infarction and ischaemia. Eur Heart J 2011; 32:790.</a></li><li><a class="nounderline abstract_t">Gould KL, Johnson NP. Myocardial Bridges: Lessons in Clinical Coronary Pathophysiology. JACC Cardiovasc Imaging 2015; 8:705.</a></li><li><a class="nounderline abstract_t">Sternheim D, Power DA, Samtani R, et al. Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; 78:2196.</a></li><li><a class="nounderline abstract_t">Sharzehee M, Seddighi Y, Sprague EA, et al. A Hemodynamic Comparison of Myocardial Bridging and Coronary Atherosclerotic Stenosis: A Computational Model With Experimental Evaluation. J Biomech Eng 2021; 143.</a></li><li><a class="nounderline abstract_t">Saito Y, Kitahara H, Shoji T, et al. Relation between severity of myocardial bridge and vasospasm. Int J Cardiol 2017; 248:34.</a></li><li><a class="nounderline abstract_t">Nam P, Choi BG, Choi SY, et al. The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis. Atherosclerosis 2018; 270:8.</a></li><li><a class="nounderline abstract_t">Bourassa MG, Butnaru A, Lespérance J, Tardif JC. Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol 2003; 41:351.</a></li><li><a class="nounderline abstract_t">Mouratidis B, Lomas FE, McGill D. Thallium-201 myocardial SPECT in myocardial bridging. J Nucl Med 1995; 36:1031.</a></li><li><a class="nounderline abstract_t">Escaned J, Cortés J, Flores A, et al. Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging. J Am Coll Cardiol 2003; 42:226.</a></li><li><a class="nounderline abstract_t">Hakeem A, Cilingiroglu M, Leesar MA. Hemodynamic and intravascular ultrasound assessment of myocardial bridging: fractional flow reserve paradox with dobutamine versus adenosine. Catheter Cardiovasc Interv 2010; 75:229.</a></li><li><a class="nounderline abstract_t">Tarantini G, Barioli A, Nai Fovino L, et al. Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation. Circ Cardiovasc Interv 2018; 11:e006247.</a></li><li><a class="nounderline abstract_t">Ishii T, Hosoda Y, Osaka T, et al. The significance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery. J Pathol 1986; 148:279.</a></li><li><a class="nounderline abstract_t">Bennett JM, Blomerus P. Thallium-201 scintigraphy perfusion defect with dipyridamole in a patient with a myocardial bridge. Clin Cardiol 1988; 11:268.</a></li><li><a class="nounderline abstract_t">Feld H, Guadanino V, Hollander G, et al. Exercise-induced ventricular tachycardia in association with a myocardial bridge. Chest 1991; 99:1295.</a></li><li><a class="nounderline abstract_t">Migliore F, Zorzi A, Marra MP, et al. Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction. Heart Rhythm 2011; 8:1629.</a></li><li><a class="nounderline abstract_t">Desseigne P, Tabib A, Loire R. [Myocardial bridging on the left anterior descending coronary artery and sudden death. Apropos of 19 cases with autopsy]. Arch Mal Coeur Vaiss 1991; 84:511.</a></li><li><a class="nounderline abstract_t">Tang K, Wang L, Shi R, et al. The role of myocardial perfusion imaging in evaluating patients with myocardial bridging. J Nucl Cardiol 2011; 18:117.</a></li><li><a class="nounderline abstract_t">Corban MT, Hung OY, Eshtehardi P, et al. Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies. J Am Coll Cardiol 2014; 63:2346.</a></li><li><a class="nounderline abstract_t">Bestetti RB, Costa RS, Zucolotto S, Oliveira JS. Fatal outcome associated with autopsy proven myocardial bridging of the left anterior descending coronary artery. Eur Heart J 1989; 10:573.</a></li><li><a class="nounderline abstract_t">Chee TP, Jensen DP, Padnick MB, et al. Myocardial bridging of the left anterior descending coronary artery resulting in subendocardial infarction. Arch Intern Med 1981; 141:1703.</a></li><li><a class="nounderline abstract_t">den Dulk K, Brugada P, Braat S, et al. Myocardial bridging as a cause of paroxysmal atrioventricular block. J Am Coll Cardiol 1983; 1:965.</a></li><li><a class="nounderline abstract_t">Bestetti RB, Costa RS, Kazava DK, Oliveira JS. Can isolated myocardial bridging of the left anterior descending coronary artery be associated with sudden death during exercise? Acta Cardiol 1991; 46:27.</a></li><li><a class="nounderline abstract_t">Migliore F, Maffei E, Perazzolo Marra M, et al. LAD coronary artery myocardial bridging and apical ballooning syndrome. JACC Cardiovasc Imaging 2013; 6:32.</a></li><li><a class="nounderline abstract_t">Yetman AT, McCrindle BW, MacDonald C, et al. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. N Engl J Med 1998; 339:1201.</a></li><li><a class="nounderline abstract_t">Mohiddin SA, Begley D, Shih J, Fananapazir L. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. J Am Coll Cardiol 2000; 36:2270.</a></li><li><a class="nounderline abstract_t">Tsujita K, Maehara A, Mintz GS, et al. Impact of myocardial bridge on clinical outcome after coronary stent placement. Am J Cardiol 2009; 103:1344.</a></li><li><a class="nounderline abstract_t">Basso C, Thiene G, Mackey-Bojack S, et al. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J 2009; 30:1627.</a></li><li><a class="nounderline abstract_t">Güner A, Atmaca S, Balaban İ, et al. Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study. Herz 2023; 48:399.</a></li><li><a class="nounderline abstract_t">Bruce C, Ubhi N, McKeegan P, Sanders K. Systematic Review and Meta-Analysis of Cardiovascular Consequences of Myocardial Bridging in Hypertrophic Cardiomyopathy. Am J Cardiol 2023; 188:110.</a></li><li><a class="nounderline abstract_t">Schwarz ER, Gupta R, Haager PK, et al. Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up. Cardiology 2009; 112:13.</a></li><li><a class="nounderline abstract_t">Schwarz ER, Klues HG, vom Dahl J, et al. Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication. J Am Coll Cardiol 1996; 27:1637.</a></li><li><a class="nounderline abstract_t">Klues HG, Schwarz ER, vom Dahl J, et al. Disturbed intracoronary hemodynamics in myocardial bridging: early normalization by intracoronary stent placement. Circulation 1997; 96:2905.</a></li><li><a class="nounderline abstract_t">Prendergast BD, Kerr F, Starkey IR. Normalisation of abnormal coronary fractional flow reserve associated with myocardial bridging using an intracoronary stent. Heart 2000; 83:705.</a></li><li><a class="nounderline abstract_t">Srinivasan M, Prasad A. Metal fatigue in myocardial bridges: stent fracture limits the efficacy of drug-eluting stents. J Invasive Cardiol 2011; 23:E150.</a></li><li><a class="nounderline abstract_t">Haager PK, Schwarz ER, vom Dahl J, et al. Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging. Heart 2000; 84:403.</a></li><li><a class="nounderline abstract_t">Hering D, Horstkotte D, Schwimmbeck P, et al. [Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. Z Kardiol 1997; 86:630.</a></li><li><a class="nounderline abstract_t">Zhang M, Kang WC, Moon CI, et al. Coronary artery perforation following implantation of a drug-eluting stent rescued by deployment of a covered stent in symptomatic myocardial bridging. Korean Circ J 2010; 40:148.</a></li><li><a class="nounderline abstract_t">Katznelson Y, Petchenko P, Knobel B, et al. Myocardial bridging: surgical technique and operative results. Mil Med 1996; 161:248.</a></li><li><a class="nounderline abstract_t">Iversen S, Hake U, Mayer E, et al. Surgical treatment of myocardial bridging causing coronary artery obstruction. Scand J Thorac Cardiovasc Surg 1992; 26:107.</a></li><li><a class="nounderline abstract_t">Ochsner JL, Mills NL. Surgical management of diseased intracavitary coronary arteries. Ann Thorac Surg 1984; 38:356.</a></li><li><a class="nounderline abstract_t">Hiratzka LF, McPherson DD, Brandt B 3rd, et al. Intraoperative high-frequency epicardial echocardiography in coronary revascularization: locating deeply embedded coronary arteries. Ann Thorac Surg 1986; 42:S9.</a></li></ol></div><div id="topicVersionRevision">Topic 1499 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427660" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Update on myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15764618" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19620504" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Anatomic properties of myocardial bridge predisposing to myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10426850" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8902676" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nonatherosclerotic causes of myocardial ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19697102" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prevalence of myocardial bridging and correlation with coronary atherosclerosis studied with 64-slice CT coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20808694" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Myocardial bridging of the left anterior descending coronary artery: depiction rate and morphologic features by dual-source CT coronary angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/307341" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Symptomatic myocardial bridging of coronary artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10562478" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8149538" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12021235" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Coronary anomalies: incidence, pathophysiology, and clinical relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7055058" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12957438" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Myocardial bridging in adult patients with hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2513117" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The incidence of myocardial bridges in heart transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32111340" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Frequency and Significance of Coronary Artery Disease and Myocardial Bridging in Patients With Hypertrophic Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35511689" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25981503" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Functional Effects of Intramural Course of Coronary Arteries and its Relation to Coronary Atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22264630" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Myocardial bridging on coronary CTA: an innocent bystander or a culprit in myocardial infarction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28007148" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1274883" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Myocardial bridging and milking effect of the left anterior descending coronary artery: normal variant or obstruction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7397963" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The mural left anterior descending coronary artery, strenuous exercise and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19914131" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Thrombosis of a coronary artery related to the myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21448858" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Morphological changes associated with hemodynamically significant myocardial bridges in sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21123275" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Myocardial bridging causing infarction and ischaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26068287" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Myocardial Bridges: Lessons in Clinical Coronary Pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34823663" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33269788" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A Hemodynamic Comparison of Myocardial Bridging and Coronary Atherosclerotic Stenosis: A Computational Model With Experimental Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28712560" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Relation between severity of myocardial bridge and vasospasm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29407892" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12575960" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7769422" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Thallium-201 myocardial SPECT in myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12875756" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Importance of diastolic fractional flow reserve and dobutamine challenge in physiologic assessment of myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19753633" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hemodynamic and intravascular ultrasound assessment of myocardial bridging: fractional flow reserve paradox with dobutamine versus adenosine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29903715" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3701494" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The significance of myocardial bridge upon atherosclerosis in the left anterior descending coronary artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3365879" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Thallium-201 scintigraphy perfusion defect with dipyridamole in a patient with a myocardial bridge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2019202" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Exercise-induced ventricular tachycardia in association with a myocardial bridge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699846" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2064513" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : [Myocardial bridging on the left anterior descending coronary artery and sudden death. Apropos of 19 cases with autopsy].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21069488" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The role of myocardial perfusion imaging in evaluating patients with myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24583304" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2759120" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fatal outcome associated with autopsy proven myocardial bridging of the left anterior descending coronary artery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7305582" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Myocardial bridging of the left anterior descending coronary artery resulting in subendocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6826987" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Myocardial bridging as a cause of paroxysmal atrioventricular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2031421" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Can isolated myocardial bridging of the left anterior descending coronary artery be associated with sudden death during exercise?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23328559" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : LAD coronary artery myocardial bridging and apical ballooning syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9780340" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11127472" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19427426" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Impact of myocardial bridge on clinical outcome after coronary stent placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19406869" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37081129" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36512852" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Systematic Review and Meta-Analysis of Cardiovascular Consequences of Myocardial Bridging in Hypertrophic Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18577881" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636548" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Functional, angiographic and intracoronary Doppler flow characteristics in symptomatic patients with myocardial bridging: effect of short-term intravenous beta-blocker medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9386156" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Disturbed intracoronary hemodynamics in myocardial bridging: early normalization by intracoronary stent placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10814636" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Normalisation of abnormal coronary fractional flow reserve associated with myocardial bridging using an intracoronary stent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21646663" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Metal fatigue in myocardial bridges: stent fracture limits the efficacy of drug-eluting stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10995410" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9417754" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : [Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20339502" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Coronary artery perforation following implantation of a drug-eluting stent rescued by deployment of a covered stent in symptomatic myocardial bridging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8935519" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Myocardial bridging: surgical technique and operative results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1439639" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Surgical treatment of myocardial bridging causing coronary artery obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6385889" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Surgical management of diseased intracavitary coronary arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3491594" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Intraoperative high-frequency epicardial echocardiography in coronary revascularization: locating deeply embedded coronary arteries.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
